Showing 1 - 8 results of 8 for search 'Shu‐Qiang Yuan', query time: 0.04s
Refine Results
-
1
-
2
-
3
Construction of a prognostic model for gastric cancer based on immune infiltration and microenvironment, and exploration of MEF2C gene function by Si-yu Wang, Yu-xin Wang, Lu-shun Guan, Ao Shen, Run-jie Huang, Shu-qiang Yuan, Yu-long Xiao, Li-shuai Wang, Dan Lei, Yin Zhao, Chuan Lin, Chang-ping Wang, Zhi-ping Yuan
Published 2025-01-01
Article -
4
Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function by Si-yu Wang, Yu-xin Wang, Ao Shen, Xian-qi Yang, Cheng-cai Liang, Run-jie Huang, Rui Jian, Nan An, Yu-long Xiao, Li-shuai Wang, Yin Zhao, Chuan Lin, Chang-ping Wang, Zhi-ping Yuan, Shu-qiang Yuan
Published 2024-03-01
Article -
5
Reduced expression of uroplakin 1A is associated with the poor prognosis of gastric adenocarcinoma patients. by Yan Zheng, Dan-dan Wang, Wei Wang, Ke Pan, Chun-yu Huang, Yuan-fang Li, Qi-jing Wang, Shu-qiang Yuan, Shan-shan Jiang, Hai-bo Qiu, Yong-ming Chen, Xiao-fei Zhang, Bai-wei Zhao, Cong Mai, Jian-chuan Xia, Zhi-wei Zhou
Published 2014-01-01
Article -
6
Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer by Shu‐Qiang Yuan, Run‐Cong Nie, You‐Sheng Huang, Ying‐Bo Chen, Si‐Yu Wang, Xiao‐Wei Sun, Yuan‐Fang Li, Ze‐Kun Liu, Yan‐Xing Chen, Yi‐Chen Yao, Yu Xu, Hai‐Bo Qiu, Yao Liang, Wei Wang, Ze‐Xian Liu, Qi Zhao, Rui‐Hua Xu, Zhi‐Wei Zhou, Feng Wang
Published 2023-12-01
Article -
7
Transcriptional landscape and predictive potential of long noncoding RNAs in peritoneal recurrence of gastric cancer by Xiao-Xia Cai, Guo-Ming Chen, Zi-Qi Zheng, Yi-Xin Yin, Shuang Wang, Li Qiao, Xiao-Jiang Chen, Bai-Wei Zhao, Jin-Ling Duan, Cheng-Cai Liang, Ruo-Peng Zhang, Cheng-Zhi Wei, Fei-Yang Zhang, Bo-Wen Huang, Ze-Xian Liu, Zhi-Wei Zhou, Dan Xie, Mu-Yan Cai, Shu-Qiang Yuan, Yuan-Fang Li, Run-Cong Nie
Published 2024-12-01
Article -
8
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial by Run-Cong Nie, Shu-Qiang Yuan, Ya Ding, Yong-Ming Chen, Yuan-Fang Li, Cheng-Cai Liang, Mu-Yan Cai, Guo-Ming Chen, Wei Wang, Xiao-Wei Sun, De-Sheng Weng, Dan-Dan Li, Jing-Jing Zhao, Xiao-Jiang Chen, Yuan-Xiang Guan, Zhi-Min Liu, Yao Liang, Ma Luo, Jun Chi, Hai-Bo Qiu, Zhi-Wei Zhou, Xiao-Shi Zhang, Ying-Bo Chen
Published 2025-02-01
Article